Ironwood Pharmaceuticals | IRWD - Current Liabilities



Ironwood Pharmaceuticals reported $39.15M in Current Liabilities for its fiscal quarter ending in December of 2024.


Current Liabilities Change Date
Acadia Pharmaceuticals USD 330.02M 27.49M Jun/2025
Agios Pharmaceuticals USD 70.41M 18.04M Jun/2025
Almirall EUR 298.52M 36.18M Jun/2025
Alnylam Pharmaceuticals USD 1.3B 225.22M Jun/2025
Amarin USD 162.41M 17.54M Mar/2025
Ardelyx USD 81.72M 3.89M Jun/2025
Astellas Pharma JPY 1.11T 46.33B Jun/2025
AstraZeneca USD 33.54B 4.41B Jun/2025
Charles River Laboratories USD 1.08B 29.38M Jun/2025
Exact Sciences USD 521.93M 19.47M Jun/2025
Halozyme Therapeutics USD 134.28M 16.1M Jun/2025
Incyte USD 1.28B 608.18M Jun/2025
Ironwood Pharmaceuticals USD 39.15M 10.24M Dec/2024
MacroGenics USD 39M 16.53M Jun/2025
Moderna USD 1.57B 32M Jun/2025
Myriad Genetics USD 151.1M 13M Mar/2025
Pacira USD 313.16M 1.57M Jun/2025
PTC Therapeutics USD 627.81M 32.42M Jun/2025
Sarepta Therapeutics USD 919.95M 314.36M Jun/2025
Takeda JPY 2.17T 336.94B Jun/2025
Ultragenyx Pharmaceutical USD 293.24M 1.58M Jun/2025